Corrao W M, Braman S S, Irwin R S
N Engl J Med. 1979 Mar 22;300(12):633-7. doi: 10.1056/NEJM197903223001201.
Six patients with chronic cough, without history of dyspnea or wheezing, had normal base-line spirometry but hyper-reactive airways, as demonstrated with methacholine. Maintenance therapy with bronchodilators promptly eliminated the cough in all patients. Three to 12 months later therapy was discontinued for three days, cough returned, and detailed pulmonary-function studies were carried out. Again, base-line values were normal, but after methacholine one-second forced expiratory volume decreased an average of 40 per cent in the patients as compared to 30 per cent in normal controls (P less than 0.001). The point of identical flow was increased by methacholine to 43.5 per cent of vital capacity in the patients, as compared to 6 per cent in normal controls (P less than 0.001), and the alveolar plateau was 4.8 deltaN2 per liter, as compared to 1.4 in normal controls (P less than 0.01). Specific airway conductance was lowered in patients and controls, but the post-methacholine value was significantly lower in the patients. On the basis of their persistently hyper-reactive airways, inducible diffuse airway bronchoconstriction and excellent response to bronchodilator therapy, these patients appear to have a variant form of asthma in which the only presenting symptom is cough.
六名慢性咳嗽患者,无呼吸困难或喘息病史,基线肺量计检查正常,但气道反应性增高,乙酰甲胆碱激发试验证实了这一点。使用支气管扩张剂进行维持治疗后,所有患者的咳嗽均迅速消失。三至十二个月后,停药三天,咳嗽复发,随后进行了详细的肺功能研究。同样,基线值正常,但乙酰甲胆碱激发试验后,患者一秒用力呼气量平均下降40%,而正常对照组下降30%(P<0.001)。患者用力肺活量相同时的呼气流量在乙酰甲胆碱激发试验后增加至肺活量的43.5%,而正常对照组为6%(P<0.001),患者的肺泡平台为每升4.8ΔN2,正常对照组为1.4(P<0.01)。患者和对照组的比气道传导率均降低,但患者乙酰甲胆碱激发试验后的数值显著更低。基于其持续存在的气道高反应性、可诱导的弥漫性气道收缩以及对支气管扩张剂治疗的良好反应,这些患者似乎患有哮喘的一种变异形式,其唯一的表现症状为咳嗽。